Coronary Drug-Coated Balloons Market
完整報告名稱與涵蓋範圍
Coronary Drug-Coated Balloons Market Size, Share & Trends Analysis Report, By Drug Coating (Paclitaxel-Coated Balloons, Sirolimus and Limus-Coated Balloons), By Application (In-Stent Restenosis, De Novo Small Vessel Disease, Bifurcation and Complex Lesions, High Bleeding Risk and Stent-Sparing Strategies), By End User (Hospitals and Cardiac Catheterization Laboratories, Ambulatory and Specialty Cardiac Centers), By Region, and Segment Forecasts, 2026-2035
報告摘要
The coronary drug-coated balloons market covers angioplasty balloons coated with paclitaxel or sirolimus-class drugs that deliver antiproliferative therapy to coronary vessels without leaving a permanent implant, used for in-stent restenosis, de novo small vessel disease, bifurcations and stent-sparing strategies in patients at high bleeding risk. Peripheral drug-coated balloons and coronary drug-eluting stents are excluded but analysed as adjacent and competing technologies.
Adoption is being driven by the first coronary indication approval in the United States, by guideline endorsement in Europe and Japan for restenosis and small vessels, and by growing clinical interest in leaving no permanent metal behind, which preserves future treatment options and may shorten dual antiplatelet therapy. Sirolimus-coated balloons with proprietary carrier technologies have expanded the category beyond paclitaxel, and large randomised trials in de novo disease are testing whether balloons can rival stents in broader populations. Reimbursement, operator technique and lesion preparation requirements, and the competitive response of stent manufacturers influence uptake, while Chinese manufacturers have built substantial domestic volumes.
Europe, Japan and China lead usage, and North America is the fastest-growing market following regulatory approval. Competition involves cardiovascular device leaders, specialist balloon companies with proprietary coatings and Chinese domestic manufacturers.
The InsightAce study supplies US$ forecasts for all drug coating, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Coronary Drug-Coated Balloons Market Snapshot
Chapter 4. Global Coronary Drug-Coated Balloons Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Drug Coating Estimates & Trend Analysis
5.1. Drug Coating & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Drug Coating:
5.2.1. Paclitaxel-Coated Balloons
5.2.2. Sirolimus and Limus-Coated Balloons
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. Application & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
6.2.1. In-Stent Restenosis
6.2.2. De Novo Small Vessel Disease
6.2.3. Bifurcation and Complex Lesions
6.2.4. High Bleeding Risk and Stent-Sparing Strategies
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. End User & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
7.2.1. Hospitals and Cardiac Catheterization Laboratories
7.2.2. Ambulatory and Specialty Cardiac Centers
Chapter 8. Coronary Drug-Coated Balloons Market: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Southeast Asia
8.3.7. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Boston Scientific Corporation
10.2. B. Braun Melsungen AG
10.3. Cordis Corporation (MedAlliance)
10.4. Concept Medical Inc.
10.5. Medtronic plc
10.6. Terumo Corporation
10.7. Biotronik SE & Co. KG
10.8. iVascular S.L.U.
10.9. Orchestra BioMed Holdings, Inc.
10.10. Surmodics, Inc.
10.11. Abbott Laboratories
10.12. Lepu Medical Technology (Beijing) Co., Ltd.
10.13. Shenzhen Yuanxing Medical
10.14. Eurocor Tech GmbH
10.15. Cardionovum GmbH
圖表清單 List of Tables & Figures
Table 1. Global Coronary Drug-Coated Balloons Market Revenue Forecast by Drug Coating, 2026-2035 (US$ Mn)
Figure 1. Global Coronary Drug-Coated Balloons Market Segmentation and Scope Overview
Table 2. Global Coronary Drug-Coated Balloons Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 2. Global Coronary Drug-Coated Balloons Market Share by Drug Coating, 2026 & 2035
Table 3. Global Coronary Drug-Coated Balloons Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 3. Coronary DCB Indication Expansion from Restenosis to De Novo Disease, 2026-2035
Table 4. Global Coronary Drug-Coated Balloons Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 4. Paclitaxel Versus Sirolimus Coating Technologies and Clinical Evidence
Table 5. North America Coronary Drug-Coated Balloons Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Coronary Drug-Coated Balloons Growth Opportunity Analysis
Table 6. Europe Coronary Drug-Coated Balloons Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Coronary Drug-Coated Balloons Market Participants
Table 7. Asia Pacific Coronary Drug-Coated Balloons Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Coronary Drug-Coated Balloons Market
Table 8. Strategic Developments of Leading Coronary Drug-Coated Balloons Market Participants, 2023-2026
Figure 8. Regional Adoption Comparison Following U.S. Approval and Guideline Updates
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們